Trial Profile
A Phase I Clinical Trial of Fluorouracil (5-FU) + CPI-613 Combination in Previously Treated Metastatic Colorectal Cancer Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Jul 2023
Price :
$35
*
At a glance
- Drugs Devimistat (Primary) ; Fluorouracil (Primary)
- Indications Adenocarcinoma; Colon cancer; Colorectal cancer; Rectal cancer
- Focus Adverse reactions
- 13 Jul 2023 Status changed from active, no longer recruiting to completed.
- 04 May 2023 Planned End Date changed from 1 Feb 2023 to 1 Jun 2023.
- 13 Sep 2022 Planned End Date changed from 1 Aug 2022 to 1 Feb 2023.